TXNDC5 and cervical cancer: TXNDC5 can also contributes to abnormal angiogenesis in cervical cancer by regulating inflammatory factor receptor expression of SERPINF1 and TRAF1, which can activate the NF-κB signaling in inflammatory environments (12, 83, 84).